1. Home
  2. MASS vs CDLX Comparison

MASS vs CDLX Comparison

Compare MASS & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASS
  • CDLX
  • Stock Information
  • Founded
  • MASS 2012
  • CDLX 2008
  • Country
  • MASS United States
  • CDLX United States
  • Employees
  • MASS N/A
  • CDLX N/A
  • Industry
  • MASS Medical/Dental Instruments
  • CDLX Computer Software: Programming Data Processing
  • Sector
  • MASS Health Care
  • CDLX Technology
  • Exchange
  • MASS Nasdaq
  • CDLX Nasdaq
  • Market Cap
  • MASS 84.3M
  • CDLX 98.2M
  • IPO Year
  • MASS 2020
  • CDLX 2018
  • Fundamental
  • Price
  • MASS $6.90
  • CDLX $1.78
  • Analyst Decision
  • MASS Buy
  • CDLX Hold
  • Analyst Count
  • MASS 3
  • CDLX 5
  • Target Price
  • MASS $5.33
  • CDLX $3.50
  • AVG Volume (30 Days)
  • MASS 699.4K
  • CDLX 1.2M
  • Earning Date
  • MASS 08-05-2025
  • CDLX 08-06-2025
  • Dividend Yield
  • MASS N/A
  • CDLX N/A
  • EPS Growth
  • MASS N/A
  • CDLX N/A
  • EPS
  • MASS N/A
  • CDLX N/A
  • Revenue
  • MASS $63,986,000.00
  • CDLX $272,588,000.00
  • Revenue This Year
  • MASS N/A
  • CDLX N/A
  • Revenue Next Year
  • MASS $22.44
  • CDLX $5.51
  • P/E Ratio
  • MASS N/A
  • CDLX N/A
  • Revenue Growth
  • MASS 32.85
  • CDLX N/A
  • 52 Week Low
  • MASS $1.81
  • CDLX $1.22
  • 52 Week High
  • MASS $8.06
  • CDLX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • MASS 53.47
  • CDLX 50.89
  • Support Level
  • MASS $6.33
  • CDLX $1.71
  • Resistance Level
  • MASS $7.27
  • CDLX $1.91
  • Average True Range (ATR)
  • MASS 0.44
  • CDLX 0.16
  • MACD
  • MASS -0.05
  • CDLX 0.01
  • Stochastic Oscillator
  • MASS 45.60
  • CDLX 50.54

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Share on Social Networks: